| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 2,843 | 2,579 | 3,608 | 2,848 | | Selling General and Administrative | 604 | 761 | 807 | 613 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,447) | (3,340) | (4,415) | (3,461) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 224 | 267 | 423 | | Earnings Before Interest And Taxes | 17,825 | (3,116) | (4,148) | (3,038) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 17,825 | (3,116) | (4,148) | (3,038) | | Income Tax Expense |
-
|
-
|
-
| (363) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 17,825 | (3,116) | (4,148) | (2,675) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,825 | (3,116) | (4,148) | (2,675) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,825 | ($3,116) | ($4,148) | ($2,675) |
|
1.48% Nasdaq 
Income Statement
